BDX vs CLOV
Becton Dickinson and Company (BDX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BDX and CLOV stock pages for the full models.
Not investment advice.